Insider · CIK 0001234880
Robert C Koski
Files at OGEN (ORAGENICS INC). First filing -, latest -.
In brief
Robert C Koski files SEC Form 4 as director at OGEN (ORAGENICS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Robert C Koski has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | OGEN ORAGENICS INC | AGrant or award Non-Employee Director Option (Right to Buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Dec 15, 2025 |
| Dec 11, 2024 | OGEN ORAGENICS INC | CConversion Common Stockindirect: See Footnote | +5,000 | - | - | 23,367 | Dec 13, 2024 |
| Dec 11, 2024 | OGEN ORAGENICS INC | CConversion Series B Convertible Preferred Stockderivativeindirect: See Footnote | -1,500,000 | - | - | 0 | Dec 13, 2024 |
Questions about Robert C Koski
Answered from the filings on this page, as of the latest one.
Is Robert C Koski buying or selling?
Robert C Koski has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Robert C Koski's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert C Koski has 0.
Where does Robert C Koski file Form 4?
Robert C Koski has filed Form 4 at OGEN (ORAGENICS INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.